Yüklüyor......
Pharmacogenetics of Tamoxifen: CYP2D6 Testing in Breast Cancer - Ready for Prime Time?
Despite recent advances in hormonal therapy for breast cancer, tamoxifen remains a major therapeutic option, with indications ranging from primary prevention to metastatic disease. Understanding the variation in response to tamoxifen may significantly improve our ability to personalize cancer care a...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3651736/ https://ncbi.nlm.nih.gov/pubmed/20120834 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|